Free Trial
→ Vladimir Lenin was right… (From Porter & Company) (Ad) Free EGRX Stock Alerts

Eagle Pharmaceuticals (EGRX) ESG Score & Sustainability Data

Eagle Pharmaceuticals logo
$0.55 -0.05 (-8.33%)
(As of 12/20/2024 04:19 PM ET)
Compare

Key ESG Takeaways for Eagle Pharmaceuticals

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Eagle Pharmaceuticals. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Eagle Pharmaceuticals seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Bendamustine, Dantrolene, and Pemetrexed products.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Bendamustine, Dantrolene, and Pemetrexed products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Eagle Pharmaceuticals would improve its net impact ratio by 2 percentage points.

EGRX Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+54.0%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+59.2%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+39.0%
Society First
Value set that emphasizes society impacts over other impacts.
-41.0%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+62.6%
Health First
Value set that emphasizes health impacts over other impacts.
+76.3%

Eagle Pharmaceuticals ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+0.70
+0.70
+1.64
+1.64
+0.28
+0.28
-0.02
+0.06
+0.08
-0.12
-0.06
+0.06
+0.00
+0.00
+0.89
+0.89
-0.00
+0.00
+0.00
-1.93
-1.93
-1.39
+6.58
+7.98
-0.02
+0.50
+0.52
0.00
+0.00
-0.00
+0.01
+0.01
-0.00
+0.44
+0.45
-1.04
-1.02
+0.02
-0.22
-0.21
+0.01
-0.09
-0.09
+0.00
-0.08
-0.08
+0.00
-0.91
-0.89
+0.01

Upright Model Version 0.4.0
ESG Data Last Updated: April 1, 2022

Ad Crypto 101 Media
The #1 Coin for November 2024
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
You can get access to the report by clicking here now…

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Eagle Pharmaceuticals ESG Score - Frequently Asked Questions

How is Eagle Pharmaceuticals doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Eagle Pharmaceuticals has a net impact ratio of 54.0%, indicating an overall positive sustainability impact. Eagle Pharmaceuticals seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Creating knowledge. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Scarce human capital, Physical diseases, and GHG emissions. Learn more on the sustainability of Eagle Pharmaceuticals.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:EGRX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...
Weiss Ratings | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
MUST SEE: The most important video in the world right now?
If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...
InvestorPlace | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Altcoin season moves fast, and those who hesitate are left behind. The window is closing.
Crypto Swap Profits | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored